Quote:

---

And we also spent most of our time, money and resources chasing COVID (which may amount to zero), instead of focusing and nailing down our approval in HIV.

---

Covid is still our quickest route to approval and having substantial revenue before any full approval is the best thing to happen to the company. Besides without making a Covid play we would probably still have Amarex fumbling the BLA.